Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
American Journal of Hematology|July 24, 2010
Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosisJae-Sook Ahn, Sung-Yoon Rew, Myung-Geun Shin, et al.Cancer Research and Treatment|April 7, 2010
Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivityJae-Sook Ahn, Yeo-Kyeoung Kim, Se Ryeon Lee, et al.Stem Cells and Development|January 15, 2011
Human feeder cells can support the undifferentiated growth of human and mouse embryonic stem cells using their own basic fibroblast growth factorsYong Park, Ji Hea Kim, Seung Jin Lee, et al.Journal of Korean Medical Science|June 23, 2009
The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemiaSe Ryeon Lee, Deok Hwan Yang, Jae Sook Ahn, et al.Scientific Reports|September 29, 2025
Adaptive immune responses associated with the progression of premalignant lesions to colorectal cancerZhishan Chen, Dongwoo Kim, Jifeng Wang, et al.The Korean Journal of Internal Medicine|June 19, 2023
Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II studyDong Won Baek, Han-Seung Park, Sang Kyun Sohn, et al.Frontiers in Oncology|February 14, 2024
Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort studySuhyeon Kim, Jiye Jung, Seo-Yeon Ahn, et al.Leukemia Research|September 19, 2009
The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic diseaseYong Park, Dae Sik Kim, Seh Jong Park, et al.Journal of Clinical Apheresis|July 9, 2019
Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myelomaYong Park, Dae Sik Kim, Min Ji Jeon, et al.Anticancer Research|July 5, 2018
The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a BiomarkerKa-Won Kang, Jik-Han Jung, Woojune Hur, et al.Pageof 7